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Abstract
Lymphocytes play important roles in the balance between body defense and noxious agents involved in a number
of diseases, e.g. autoimmune diseases, allergic inflammation and cancer. The proteomic analyses have been applied
to identify and validate disease-associated and disease-specific biomarkers for therapeutic strategies of diseases. The
proteomic profiles of lymphocytes may provide more information to understand their functions and roles in the
development of diseases, although proteomic approaches in lymphocytes are still limited. The present review
overviewed the proteomics-based studies on lymphocytes to headlight the proteomic profiles of lymphocytes in
diseases, such as autoimmune diseases, allergic inflammation and cancer, with a special focus on lung diseases. We
will explore the potential significance of diagnostic biomarkers and therapeutic targets from the current status in
proteomic studies of lymphocytes and discuss the value of the currently available proteomic methodologies in the
lymphocytes research.
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Introduction
Lymphocytes play central and pivotal roles in immune
defense mechanisms against pathogens and controls of the
immune responses, including protective responses against
pulmonary pathogens and lung diseases, e.g. asthma, sar-
coidosis, idiopathic pulmonary fibrosis, or alveolitis [1-4].
The emergence of genomics, proteomics, and bioinformat-
ics allows defining gene expression and/or protein profile in
lymphocytes to furthermore understand interactions bet-
ween the components within targeted signaling network,
even though a number of challenges still exist. The protein
expression and post-translational modifications profiled by
proteomics can explore functional interactions between
proteins and develop disease-specific biomarkers by inte-
grating with clinical informatics [5-7]. Proteomic tools
and strategies are used to elucidate mechanisms and
function of lymphocyte signaling and biology, including
glycoprotein, phosphoprotein, membrane protein, single
protein, quantitative protein and organelle [8]. Localizations,
post-translational modifications, interactions, or turnovers of
proteins produced by lymphocytes are summarized in
Table 1. The present review overviewed the proteomics-
based studies on lymphocytes to headlight the proteomic
profiles of lymphocytes in diseases, such as autoimmune
diseases, allergic inflammation and cancer, with a special
focus on lung diseases. We will explore the potential
significance of diagnostic biomarkers and therapeutic
targets from the current status in proteomic studies of lym-
phocytes and discuss the value of the currently available
proteomic methodologies in the lymphocytes research.
Autoimmune diseases
The production of auto-antibodies from T- and B- lym-
phocytes were associated with lymphocyte-mediated im-
mune responses [9]. Forty-two proteins were differentially
expressed in human CD4
+ Tcells during the differentiation
of naïve CD4
+ T cells into Th1 cells induced by interleukin
(IL)-12, of which 22 and 20 were up- and down- regulated
respectively [10], as shown in Table 2. In this particular
study, macrophage migration inhibitory factor and pro-
grammed cell death 4 involved in cell rescue, defense,
death and ageing were up-regulated. Macrophage migra-
tion inhibitory factor contributes to pro-inflammatory,
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polymorphisms were associated with T helper cell-related
disorders [11,12]. Down-regulation of p21-activated kinase
2, GTPase Cdc42, and a heat shock family member morta-
lin 2 may promote lymphocyte survival and protection
from programmed cell death.
Proteins involved in the T cell proliferation were defined
during the suppression of PHA-treated Tcells isolated from
healthy donors, of which 13 proteins, e.g. peroxiredoxin-1,
proteasomes and triosephospohate isomerase increased,
while 4 like galectin-1 and Chain A reduced [13], as listed
in Table 2. The identified differentially expressed proteins
in lymphocytes were mainly involved in energy metabolism
[14], anti-inflammatory pathways [15], oxidative stress [16]
and protein breakdown [17], while a few were related to
immune cell migration [18] and molecular chaperone
[19]. T cell activation was inhibited by special inhibitors,
e.g. cyclosporine A, polysaccharopeptide, or medical fungal
products, through the alteration of proteins associated with
the cell proliferation, including proteasomes, triosephospo-
hate isomerase, galectin-1, Chain A, or perxiredoxin-1,
respectively. Most of the altered proteins have functio-
nal significance in protein degradation [20], antioxidant
pathway, energy metabolism [21], and immune cell
regulation [22].
The intranasal delivery of auto-antigen could effectively
induce mucosal tolerance and suppression of autoimmune
diseases. Proteomic profiles of cervical lymph nodes were
investigated to identify markers of the tolerant state 24, 48
and 72 h after nasal administration of antigen [23]. Of
them, haptoglobin, nonintegrin 67 kDa laminin receptor
(also known as P40-8), or Calgranulin A (MRP8) were
related to the tolerance of immune through altering
migration/mobility of antigen presenting cells and/or T
cells [24,25] and anti-inflammatory activities [26]. The
application of irradiated T cells as T-cell vaccination
showed preventive effects and experimental treatment in
autoimmune diseases, through induction and production
of anti-lymphocytic antibodies and inhibition of T-cell
proliferation.
Proteomics is used not only for the identification and
validation of biomarkers, but also for the characterization
of the antigen specificity. Eleven antigens were identified
in mouse T cells activated by ovalbumin and recognized
by anti-T cell antibodies after the animals were immu-
nized with ovalbumin-specific T cells, of which damage-
Table 1 Categories of study design and techniques in lymphocyte proteomics
Ref. Disease/Activity Total identified
proteins
Samples Country Proteomic methods
10 IL-12 regulated CD4+ T cells
differentiation
42 Blood Finland 2-DE
MS
13 T cell proliferation 17 Blood Hong Kong,
China
2-DE
MALDI-TOF MS
23 Mucosal tolerance 11 Lymph node Netherlands 2D-PAGE
MALDI-TOF MS
27 T-cell vaccination (TCV) 11 Activated mouse
ovalbumin-specific T cells
P. R. China 2-DE
Q-TOF MS
28 Vogt-Koyanagi-Harada (VKH) syndrome 30 Blood United States of America LC-MS/MS
29 Rheumatic heart disease (RHD) 3 Blood Brazil 2-DE
Cardiac tissue MALDI-TOF MS
32 Tyrosine phosphorylation 3 Primary human
lymphocyte
United States of America 2D-PAGE
37 Immunosuppression 10 E6-1 cell line Spain 2D-PAGE
38 Colitis 26 Lymph node P. R. China 2D-PAGE
MS
45 Pseudomonas aeruginosa sepsis 11 Blood P. R. China 2-DE
MALDI-TOF MS
46 DNA repair capacity (cell-cycle
checkpoint-related protein)
8 Blood United States of America Reverse-phase protein
lysate microarray assay
49 Asthma 25 Blood South Korea 2D-PAGE
MALDI-TOF MS
50 Asthma 13 Blood Taiwan, China 2D-PAGE
LC/MS
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dominant [27]. γ-radiation was found to induce the
immunogenic apoptosis of activated T cells. Exposed/
secreted damage-associated molecular pattern molecules,
e.g. calreticulin, endoplasmic reticulum protein 57, and
vementin, played an important role in T-cell vaccination
therapy (Table 2).
T cells are considered as a major player in Vogt-
Koyanagi-Harada (VKH) syndrome, an autoimmune
disorder, which mainly affects systemic melanocytes in
eyes, menings, ears, skin, or hairs. Membrane proteins in
CD4
+ T cells from patients with active VKH syndrome
were analyzed with a label-free quantitative proteomic
strategy to identify disease-associated proteins as com-
pared with healthy individuals [28]. 102 significantly
altered peptides were identified and corresponded to 64
proteins, of which 30 had 1.5-fold alterations, as summa-
rized in Table 3. The expression of CD18 and AT-hook
transcription factor decreased and then further validated
in an additional group of patients with VKH syndrome,
major players in the pathogenesis of the syndrome. Mo-
lecular mimicry between group A streptococcus antigens
and host proteins was investigated in B and T cells from
patients with rheumatic heart disease with the major
manifestation of rheumatic fever due to streptococcus
pharyngitis. Three proteins in heart infiltrating and
peripheral T cells isolated from the valvular tissue from
patients with chronic rheumatic heart disease were iden-
tified as T cell-targeted proteins, e.g. disulfide isomerase
ER-60 precursor, 78 kD glucose-regulated protein precur-
sor, and vimentin, with coverage of 45, 43, and 34%,
respectively [29]. They were believed similar to antigens
involved in T cell-mediated autoimmune responses in
rheumatic fever/rheumatic heart diseases.
Allergic inflammation
Lymphocytes and their products, together with other leu-
kocytes, contribute to the initiation and perpetuation of
the inflammatory response, through the alterations of pro-
tein profiles [30]. Protein tyrosine phosphorylation was
suggested to play a critical role in regulation of gene tran-
scription, cell proliferation, differentiation, cytoskeletal
organization, and survival in lymphocytes during the
development of tissue remodeling in chronic inflammation
induced by allergen [31]. Protein profiles associated with
tyrosine phosphorylation were investigated in Daudi, Bur-
kitt’s lymphoma-derived B cell lines, and BJAB, B cell
lymphoma-derived B cell lines, using a battery of Src hom-
ology 2 domain probes, and similar patterns of tyrosine
phosphorylation for the Fyn and phosphatidylinositol-3-
kinase Src homology 2 were found but not in Crk Src
homology 2 [32]. The fingerprinting of proteins associated
Table 2 Dominant proteins associated with T cell activities
Ref. Activity Protein Expression Functions
10 T cell differentiation Macrophage migration inhibitory factor (MIF) Up-regulated Cell resque, defense, death, ageing
Programmed cell death 4 (pdcd4) Up-regulated Cell resque, defense, death, ageing
p21-activated kinase 2 (Pak2) Down-regulated Signal transduction
Cdc42 Down-regulated Signal transduction
Mortalin 2 (Mot-2) Down-regulated Protein destination
13 T cell proliferation Peroxiredoxin 1 Up-regulated A scavenger of reactive organic hydroperoxides
Proteasomes Up-regulated A large multisubunit proteolytic complex that
involved in an ATP/ubiquitin-dependent
non-lysosomal proteolytic pathway
Triosephosphate isomerase (TIM) Up-regulted Enzyme of metabolic pathways like converting
glyceraldehyde-3-phosphate to dehydroxyacetone
phosphate in the glycolytic pathway
Galectin-1, Chain A Down-regulated An anti-inflammatory agent which triggers
homeostatic signals to shut off T cell effector
functions such as cell proliferation, cell death and
cytokines synthesis, cell adhesion and
inflammation
23 T cell supression Haptoglobin Up-regulated Anti-inflammatory activities
Nonintegrin 67 kDa laminin receptor (LR) Down-regulated Lymphocyte migration
MRP8 Up-regulated Marker proteins for activated or recruited
phagocytes
27 T cell activation Calreticulin (CRT) Identified Damage-associated molecular pattern molecules,
inducing immunogenic apoptosis
Endoplasmic reticulum protein (ERp57)
Vimentin
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interferon (IFN)-γ in human lymphocytes demonstrated
that IFN-γ could induce STAT2 phosphorylation, IL-2-
activated phosphatidylinositol-3-kinase phosphoprotein, or
both, involved in phosphorylation of transcription factor
Jak-1 by anti-phosphotyrosine immunoprecipitations and
proteomic analysis [33]. Chromatin-associated regulatory
factors play central roles in the regulation of cell prolifer-
ation, differentiation, senescence, and death in lympho-
cyte. Proteomic analysis of chromatin-associated proteins
Table 3 The differentially expressed proteins identified in CD4
+ T cells between active VKH patients and normal
individuals
Identified proteins Expression Number of peptides Function
Integrin β Up-regulated Singe Protein binding
Coronin-2A Up-regulated Singe Protein binding
C19orf2 protein Up-regulated Singe Protein binding
Isoform 4 of Dystrophin Up-regulated Singe Structural constitute of cytoskeleton, muscle;
protein, calcium ion, actin, zinc ion binding
Synaptonemal complex protein 2 Up-regulated Singe DNA binding
Hypothetical protein LOC345651 Up-regulated Singe Protein binding
Isoform 1 of Solute carrier family 22
member 11
Up-regulated Singe Sodium-independent organic anion
transporter activity
UBC; UBB ubiquitin and ribosomal protein
S27a precursor
Up-regulated Singe Structural constituent of ribosome
PRA1 family protein 3 Up-regulated Singe Protein binding
Actin, cytoplasmic 1 Up-regulated Singe Structural constituent of cytoskeleton; protein,
ATP, nucleotide binding
Probable G-protein coupled receptor 179
precursor
Up-regulated Singe Metabotropic glutamate, GABA-B-like receptor
activity
Heat shock 70 kDa protein 9, mitochondrial
precursor
Up-regulated Singe Unfolded protein binding; ATP, nucleotide
binding
ELMO2 protein Up-regulated Singe Binding
Isoform 1 of Peripherin Down-regulated Singe Structural molecule activity
ATP synthase subunit α, mitochondrial
precursor
Down-regulated Singe Protein, ATP, nucleotide, metal ion binding;
hydrogen-transporting ATPase/ATP synthase
activity; hydrolase, transporter activity
Calnexin precursor Down-regulated Singe Calcium ion, sugar binding; unfolded protein
binding
Integrin β-2 precursor Down-regulated Singe Protein, protein kinase binding; receptor
activity
Vimentin Up-regulated Two or more Structural constituent of cytoskeleton; protein
binding; structural molecule activity; oxygen
transporter activity
Keratin, type I cytoskeletal 10 Up-regulated Two or more Structural constituent of epidermis; structural
molecule activity
ATP synthase subunit β, mitochondrial
precursor
Up-regulated Two or more Protein, ATP, nucleotide, metal ion binding;
hydrogen-transporting ATPase/ATP synthase
activity; hydrolase, transporter activity;
hydrogen-exporting ATPase activity;
nucleotide-triphosphatase activity
Actin, aortic smooth muscle Up-regulated Two or more Structural constituent of cytoskeleton; protein,
ATP, nucleotide binding
Keratin, type II cytoskeletal 1 Up-regulated Two or more Structural constituent of cytoskeleton; protein,
sugar binding; receptor activity
Uncharacterized protein ALB Up-regulated Two or more Protein, water, toxin, pyridoxal phosphate,
drug, fatty acid, oxygen, copper ion, DNA,
metal ion binding; carrier, antioxidant activity
Isoform ASF-1 of Splicing factor,
arginine/serine-rich 1
Down-regulated Two or more Protein, nucleotide, RNA binding
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varied in human B cells (P493-6 cells) expressing c-Myc
in a tetracycline-repressible manner [34].
Proteomic profiles in lymphocytes were analyzed under
challenges with concanavalin A-stimulated mouse spleen
cells cultured with or without cyclosporine A and re-
stimulated in the presence or absence of concanavalin A,
to monitor the response of protein profiles to immunosup-
pressions and activations [35]. Cyclosporine A was found
to activate and program the transcription and translation
of a large number of genes in Tcells without further reacti-
vation, once the immunosupressor and the activator were
removed. Cyclosporine A could induce down-regulation of
immune responses through the calcineurin-dependent
dephosphorylation of nuclear factors in activated T cells,
which was interfered by new and specific synthesized poly-
peptides without affecting the expression of CD44 and
CD69 and early tyrosine phosphorylation-associated pro-
tein profiles [36]. Of 111 protein spots altered in human T
cells cultured with the potent immunosuppressant rapamy-
cin, 70 increased and 41 decreased, of which annexin V
and Ro/SSA antigen increased and α-enolase and laminin
receptor 1 decreased [37].
There is increasing evidence to show that altered
proteomic profiles of lymphocytes could dominate the
development of allergic inflammation. For example, al-
tered protein profiles of lymphocytes were investigated
in an antigen-specific model of colitis induced by colonic
administration of trinitrobenzene sulfonic acid/ethanol
[38]. Of 1,100 protein spots, 26 proteins had more than
at least two-fold differences between colitis and control,
among which 17 up-regulated and 9 down-regulated,
including CARD and PYD domain containing protein,
proteasome activator complex subunit 2, IL-12 p40 pre-
cursor, nucleoside diphosphate kinase, ubiquitin-conjugating
enzyme E2N, myeloid-related protein-14, ATP-citrate syn-
thase, phosphoglycerate mutase and dismutase. The altered
proteins served as regulators of the cell cycle and cell prolif-
eration [39], signal transduction factors [40,41], inflamma-
tory factors [42], apoptosis-related proteins [43,44] and
metabolic enzymes, as illustrated in Figure 1. Alterations of
protein profiles in lymphocytes in allergic diseases differed
from those in serious diseases and bacterial infection [45].
Altered protein profiles in severe burn and Pseudomonas
aeruginosa sepsis were found to be associated with the fold-
ing, assembling, transportation and degradation of proteins,
signal transmission, inflammation, immunization, energy
metabolism, the proliferation, differentiation and apoptosis
of cells, including Cofilin, peptidyl-prolyl cis-trans isomerase
cyclophilin A, ubiquitin, nucleoside diphosphate kinase,
glutamate dehydrogenase, selenium binding protein I,
beta-actin, peroxiredoxin-6, annexin I, actin-3 and cellu-
lar retinoic-acid binding protein.
Cancer
The innate DNA repair capacity (DRC) is the central in
controlling multistage carcinogenesis, and suboptimal
DRC in peripheral lymphocytes was suggested as a can-
cer susceptibility marker and a functional link between
DNA damage sensing, cell-cycle checkpoint, and DNA
Figure 1 Altered protein profile of lymphocytes from rats with colitis. The altered proteins of lymphocytes in colitis fell into the following
groups: apoptosis-related proteins, proteins associated with cell growth, differentiation and signal transduction, inflammation factors, proteins
associated with metabolism and oxidative stress response. IL-12, interleukin-12; NDPKs, nucleoside diphosphate kinases; E2 N, ubiquitin-conjugating
enzyme; NF-κB, nuclear factor κB.
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tein expressions in stimulated lymphocytes could predict
DRC levels. The host-cell reactivation assay and the
reverse-phase protein lysate microarray assay demonstrated
that the DRC was significantly correlated with expression
levels of cell-cycle checkpoint-related proteins, e.g. cyclin
dependent kinase inhibitor (p27), cell cycle regulator (cyclin
D1), DNA damage sensor (ataxia-telangiectasia mutated),
and p53-negative regulator (mouse double minute 2 homo-
log), induced by benzo[a]pyrene diol epoxide-adducts [46].
Ataxia-telangiectasia mutated was identified as the most
important predictor of DRC, followed by mouse double
minute 2 homolog and p27, a population-based in vitro
evidence that cell-cycle checkpoint-related proteins may
play essential roles in the regulation of DNA repair in un-
affected human peripheral blood lymphocytes. CD8
+ Tcells
are considered as the major players in immune responses
against cancer, with the cytotoxic activity and capability to
release various mediators. Studies on network and func-
tional characterization of proteins specific to resting or acti-
vated human CD8
+ T cells provide new insight into the
signaling pathway of CD8
+ T cell activation with anti-CD3
and anti-CD28 mAb in the presence of IL-2 [47]. The
altered expression of 35 proteins were mainly related with
cell proliferation, metabolic pathways, antigen presentation,
intracellular signal transduction pathways, as well as identi-
fication of six unknown proteins and predicted from gen-
omic DNA sequences specific to resting or activated CD8
+
Tcells.
Lung diseases
Asthma
Asthma is a complex disorder characterized by airway in-
flammation, goblet cell hyperplasia with mucus hypersecre-
tion, and hypersponsiveness to various nonspecific stimuli.
CD4
+ T lymphocytes, especially Th2 lymphocytes, play an
important role in the initiation, progression and persistence
of asthma [48]. The expression of 13 proteins increased
and 12 decreased in T lymphocytes from asthmatic pa-
tients, as compared to the healthy [49]. Among them,
phosphodiesterase 4C, heat shock protein (HSP)-70, pro-
tein tyrosine phosphatase, β-arrestin-1b, thioredoxin-like
2, LLR protein, glutathione reductase, major histocom-
patibility complex class I antigen, epidermal growth
factor receptor, pyrroline 5-carboxylate reductase isoform,
and FLJ25770 protein increased, while dynein, cytoplasmic
light intermediate polypeptide 2, vimentin, zinc finger
protein 76, tubulin β2, T-cell receptor β-chain, cyclin-
dependent kinase 6, pyridoxal kinase, phenylalanine
hydroxylase, glutathione S-transferase-M3, and tetratrico-
peptide repeat-containing protein decreased. Of identified
proteins, increased mRNA expression of phosphodiester-
ase 4C and thioredoxin-2 and decreased mRNA of
glutathione S-transferase-M3 were further confirmed by
RT-PCR in the large population of asthmatic patients.
Figure 2 demonstrates some of the identified proteins
and their role in asthma. To investigate the changes of
proteins in T lymphocytes of asthmatic patients after
no typical therapy (uncontrolled) to typical therapy
(controlled) over 3 months, 7 proteins increased and 6
decreased in CD4
+ T lymphocytes from uncontrolled
asthmatic patients, including HSP-70, HSP-90, fibrinogen
β chain, tropomyosin 3, ATP-dependent DNA helicase II,
β-actin, vimentin, Rho GDP dissociation inhibitor beta, eno-
lase 1, calreticulin precursor, tyrosine 3-monooxygenase/
tryptophan 5-monooxygenase activation protein (YWHA),
or peroxiredoxin 2, as compared to those from controls [50].
Two studies showed that HSP-70 increased and vimentin
decreased in asthmatics and uncontrolled asthmatics. HSP is
a ubiquitous, abundant, and conserved protein and synthetic
rate of HSP increased in response to cellular stress, to pro-
tect the cells and tissues from the deleterious effects of
numerous mediators, reactive oxygen species, or tumor ne-
crosis factor-α. Other studies suggested that HSP is corre-
lated with the severity of asthma exacerbation [51,52].
Vimentin, as a kind of cytoskeletal proteins and a type III
intermediate filament protein normally expressed in cells of
mesenchymal origin, attaches to the nucleus, endoplasmic
reticulum, and mitochondria to control the shape, motility,
and migration of mesenchymal cells [53]. The cytoskeletal
changes in T lymphocytes of asthma patient may contribute
to enhanced activity of proinflammatory and immune cells,
reduced antioxidant defenses, functional changes in the T
lymphocyte of asthma patient, or abnormal repair process
responsible for airway inflammation and remodeling during
damage to the epithelium. Such panel of altered proteins as-
sociated with the pathogenesis of asthma could be potential
biomarkers and therapeutic targets in asthma.
Idiopathic Pulmonary Fibrosis (IPF)
IPF is a devastating disease characterized by a progressive
distortion of the alveolar architecture and replacement
by fibrotic tissue and extracellular matrix deposition.
There are still no effective therapies for IPF which results
in chronic respiratory failure and death associated with
autoimmunity, though mechanism of autoimmunity in-
volvement in the pathogenesis of IPF remains unclear.
The expression of 51 proteins increased and 38 decreased
in lungs of patients with sporadic IPF, as compared with
healthy controls [54]. Up-regulated expression of markers
for the unfolded protein response, HSP, and DNA damage
stress markers indicated a chronic cell stress-response in
IPF lungs. Down-regulated proteins in IPF included anti-
oxidants, annexin family, and structural epithelial pro-
teins, related with redox imbalance, epithelial cell injury,
extensive fibrotic reaction, and increased susceptibility of
IPF patients to infection. Proteomic analysis also identified
for the first time the presence of anti-periplakin (PPL)
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patients with IPF [55]. PPL is a small protein from the
plakin family, closely related to envoplakin and localized
to demosomes and intermediate filaments [56]. PPL is
constitutively expressed in both bronchial and alveolar
epithelia and the intracellular distribution of PPL is modi-
fied in the hyperplastic alveolar epithelium of fibrotic
lungs. PPL interacts with intermediate filaments in the
cell and is required for the reorganization of keratin inter-
mediate filaments network at the wound edge of simple
epithelia cell monolayers and for the correct closure of an
experimental wound [57]. The C-terminal domain of PPL
can be linked to several intracellular proteins, such as
protein kinase B ATK1/PKB [58] or FcγRI [59], leading to
changes in cellular functions. Anti-PPL antibodies have
the potential to interfere with alveolar repair and are asso-
ciated with the severity of the disease, indicating that the
abnormal responses of autoimmune contribute directly to
the pathogenesis of IPF.
Lung cancer
Lung cancer is the most common cause of cancer-related
mortality in the world, resulting in an overall 5-year
survival rate of approximately 15% [60]. Proteome
components related to therapeutic responses and
targeted proteins in lung cancer cells and tissues were
identified to define potential biomarkers with diagnos-
tic, prognostic, and predictive values or drug-targeted
candidates. To achieve a difference in the management
of lung cancer, short of preventing its development, it
is important to diagnose it early while it is measurable
yet presymptomatic. The development of specific and
sensitive diagnostic biomarkers from biological fluids,
such as sputum, blood, or exhaled breath, should im-
prove early detection strategies, monitoring of disease
progression, treatment response, and surveillance for
recurrence.
Proteomic methodologies
Proteins are separated from cells and then subjected to
complexity reduction, either via chromatographic or
electrophoretic fractionation, or via enrichment of de-
sired components, like membrane proteins, a particular
sub-cellular component, or specific protein complex
separation via affinity purification. Proteins can be identi-
fied via proteolysis and analysis of resultant peptides in
mass spectrometer (MS), followed by database-searching.
MS is an indispensable core of proteomic technologies and
allows highly sensitive and high-throughput identification
of proteins, post-translational modifications, or protein
interaction [61,62]. Two-dimensional gel electrophoresis
for separation of complex protein samples from blood,
lymph nodes or cell lines, coupled with MS for protein
identification, can analyze protein expression patterns for
profiling lymphocyte proteomics, as shown in Table 1. A
large variation of MS technologies is currently available,
Figure 2 Altered protein profiles of T cells from asthma patients. PDE4, hydrolyzing cyclic adenosine monophosphate and/or cyclic
guanosine monophosphate, was associated with the MUC5AC expression in human airway epithelial cells. β-Arrestin was suggested to play a role
in T cell migration. Glutathione reductase, GST-M3 and thioredoxin were correlated with the antioxidant capacity. HSP-70 protects the cells and
tissues from the deleterious effects of numerous mediators, reactive oxygen species, or tumor necrosis factor-α. Cytoskeletal proteins, including
Dynein, Vimentin, Tubulin β2, might illustrate the functional changes in the T cells. Cyclin-dependent kinase was related to an abnormal repair
process that might contribute to airway inflammation and remodeling. PDE, phosphodiesterase; HSP, heat shock protein; GST, glutathione
S transferase.
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laser desorption/ionization (MALDI) to a new generation
of mass analyzers and complex multistage instruments
[such as hybrid quadrupole time-of-flight (Q-TOF)]
[61,63]. The MS technologies in lymphocyte proteomics
include MALDI-TOF, MS/MS (tandem MS), or Q-TOF.
MALDI-TOF-MS can identify a wide mass range (1–
300 kDa) of proteins in lymphocytes with a high
accuracy and sensitivity and analyse post-translational
protein modifications [64]. In combination with others,
MALDI-TOF-MS is particularly suitable for the identi-
fication of protein spots via mass fingerprint or micro-
sequencing. Peptide mass fingerprinting (PMF) by
MALDI-MS and sequencing by tandem MS have
evolved into the major methods for identification of
protein following separation by two-dimensional gel
electrophoresis, sodium dodecyl sulfate polyacrylamide
gel electrophoresis, or liquid chromatography. The
PMF for protein identification is exemplified with high
molecular masses, low molecular masses, splice variants,
aggregates with disulfide bridges, and phosphorylated
proteins [65]. It is necessary to quantitatively determine
the changes of proteomes or sub-proteomes in responses
to stimuli and to fully elucidate lymphocyte signaling
mechanisms and function. Isotope-coded affinity tagging
is one of the most employed chemical isotope labeling
methods and the first quantitative proteomic method to
be based solely on using MS [66,67], and has been
applied to a wide range of biological systems, including
lymphocyte signaling [34,68]. By labeling cysteine resi-
dues of proteins from two different sources with
12C and
13C, respectively, isotope-coded affinity tagging allows
comparison and relative quantitation of two or more
bio-samples.
Therapeutic significance
Proteomic approaches can determine expressed proteins in
lymphocytes and describe the interactions between proteins
and targeted regulatory signaling networks. Lymphocytes
are a central component of immune defense mechanisms
against pathogens and novel therapeutic strategies towards
diseases. Identified profiles of tyrosine phosphorylation
[31], proliferation [13], cell activation [37], or chromatin-
associated proteins [34] in lymphocytes can help to build a
comprehensive view of therapeutic strategies for diseases.
CD20 and CD23 are immune regulators as therapeutic
targets for heamatological malignancies, autoimmune
diseases and allergic disorders, and a new subset of pal-
mitoylated proteins in B cells [69].
Conclusions
The understanding of lymphocyte profiles is one of the
most critical approaches to investigate their functions and
roles in the development of diseases. The proteomics-
based studies on lymphocytes headlight the proteomic
profiles of lymphocytes in diseases, such as autoimmune
diseases, allergic inflammation and cancer, with a special
focus on lung diseases. Proteomic studies of lymphocytes
provide the potential significance of disease-specific diag-
nostic biomarkers and therapeutic targets. There is an
urgent need of standard protocols to carry out proteomic
studies on lymphocytes. The current achievements in pro-
filing protein expression in lymphocytes will open the new
window to develop therapeutic strategies and targets.
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